Who is Canabossem:

Canabossem is engaged in the development and manufacture of cannabis and non-cannabis products to be sold under the Canabossem and related brands and intends to cultivate, process and sell marijuana in those states where such cultivation, processing and sales are legal.

Why Canabossem:

Florida’s recent passage of the Florida Medical Marijuana Legalization Initiative, otherwise known as Amendment 2, opens significant new opportunities for statewide medical marijuana sales.  It takes effect two years after the previously enacted Compassionate Medical Cannabis Act, which allowed for limited medical use, and paves the way for much expanded statewide medical marijuana production and increased consumption among a greater population of licensed patients.  A recent report from industry analyst ArcView Market Research projects that Florida’s medical marijuana market could reach $1.5 billion by 2020, working off a blueprint established in several other states.